Inactive Instrument

Press Releases Clinigen Group plc

Equities

JCR Pharmaceuticals implements IZCARGO Named Patient Supply Program	23-03-28	AQ
Clinigen : Supplier Code of Conduct 2023	23-03-28	PU
Adragos Pharma acquires Clinigen's development unit, Lamda Laboratories	23-03-20	AQ
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories	23-03-20	AQ
Clinigen : Global Human Rights & Anti Slavery Policy	23-03-10	PU
Clinigen : Global Anti-Bribery & Corruption Policy	23-03-10	PU
Clinigen : Global Anti-Money Laundering Policy	23-03-10	PU
Clinigen : Global Anti-Trust Policy	23-03-10	PU
Clinigen : Global Health & Safety Policy	23-03-10	PU
Clinigen : Global Freedom to Speak Up Policy	23-03-10	PU
Clinigen : Global Data Protection Policy	23-03-10	PU
Clinigen : Global Diversity, Equity & Inclusion Policy	23-03-10	PU
Clinigen : Global Environmental Policy	23-03-10	PU
Clinigen : Global Human Rights & Anti Slavery Policy	23-02-03	PU
CLINIGEN NOTES RESULTS FROM THE MIROCALS TRIAL INVESTIGATING LOW DOSE PROLEUKIN IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS	22-12-09	AQ
Clinigen : notes results from the MIROCALS trial investigating low dose Proleukin® (aldesleukin) in patients with amyotrophic lateral sclerosis	22-12-08	PU
Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services	22-05-24	AQ
Clinigen : Triton Acquisition of Clinigen	22-04-05	PU
Form 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc	22-04-04	AQ
Form 8.3 - [Clinigen Group plc - 28 03 2022] - (CGWL)	22-03-29	AQ

No results for this search